Summary Of Loading Off Bottom - As At Close Oct

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
160
Summary Of Loading Off Bottom - As At Close Oct 29.

Bought at .4000:

Aug 29: 400

Bought at .3500:

Aug 29: 100

Bought at .3000 / .3200 / .3275

Aug 28: 42,000
Oct 24: 2,599
Oct 26: 7,635
Oct 29: 4,915
Oct 30: 900

Total: 58,049

Bought at .2500 / .2553 / .2600 / .2779 / .2788 / .2800 / .2843 / .2887 / .2888 / .2998 / .2999

Sep 24: 45,374
Sep 15: 124
Oct 2: 990
Oct 18: 26,616
Oct 19: 25,000
Oct 22: 11,500
Oct 23: 10,000
Oct 24: 10,000
Jan 2: 1,000

Total: 130,604

Bought at .2045 / .2100 / .2194 / .2300 / .2325 / .2350 / .2400 / .2469:

Aug 29: 200
Sep 24: 5,194
Sep 27: 2,425
Oct 1: 10,000
Oct 12: 155
Oct 22: 520
Oct 26: 8
Oct 30: 30
Nov 5: 1
Nov 8: 3,469
Nov 9: 800
Nov 27: 5,150
Dec 4: 400
Dec 14: 1,490
Dec 18: 3,245
Dec 28: 132
Jan 7: 500
Feb 14: 503
Oct 29: 68

Total: 34,280


Bought at .2000:

Aug 28: 63,000
Sep 21: 6,499
Sep 25: 10
Sep 26: 2,500
Feb 14: 100
Feb 26: 500
Feb 27: 383
Mar 4: 533

Total: 73,025

Bought at .1600 / .1650 / .1670 / .1690 / .1700 / .1800 / .1900 / .1940 / .1995:

Aug 31: 800
Sep 21: 2,683
Oct 2: 200
Oct 8: 10,000
Oct 15: 613
Oct 16: 5,187
Oct 17: 2,500
Nov 8: 9,100
Nov 9: 1,300
Nov 12: 10,130
Nov 13: 10,000
Nov 14: 8,008
Jan 10: 22,000
Mar 21: 100
Mar 22: 100

Total: 80,621

Bought at .1500 / .1501 / .1510 / .1525 /.1530 / .1550:

Aug 31: 1,990
Sep 21: 14,154
Oct 10: 413
Oct 11: 300
Oct 12: 200
Oct 15: 9,387
Nov 16: 1
Nov 19: 66
Nov 27: 150
Dec 31: 764
Jan 7: 11
Jan 8: 3,572
Jan 22: 2
Feb 1: 1,500
Mar 4: 1,180
Mar 6: 150

Total: 33,840

Bought at .1405 / .1425 / .1440 / .1450 / .1475:

Sep 13: 1,541
Sep 14: 580
Sep 18. 20,000
Aug 6: 100
Aug 26: 4,000

Total: 26,221

Bought at .1400:

Aug 31: 6,800
Sep 5: 100
Sep 12: 19,900

Total: 26,800

Bought at .1300 / .1350:

Aug 31: 9,900
May 21: 100
May 22: 100

Total: 10,100

Bought at .1200 / .1250 / .12555 / .1270:

Aug 30: 8,000
Aug 31: 999
Sep 17: 5,100
Sep 18: 6,200
Sep 20: 1,260
Nov 30: 75
Dec 3: 50
Dec 6: 9
Dec 10: 1
Dec 17: 1
Dec 28: 700
Sep 13: 100
Sep 30: 110

Total: 22,605

Bought at .1011 / .1045 / .10505 / .1051 / .1075 / .1100 / .1150

Sep 5: 5,000
Dec 24: 20
Jan 9: 33
Jan 22: 1
Jan 24: 4
Jan 25: 1,001
Jan 26: 7,493
Feb 8: 400
Feb 20: 5
Feb 21: 2
Mar 12: 2
Apr 2: 311
May 7: 480
Sep 5: 9
Oct 10: 3,000
Oct 11: 11,675

Total: 29,436

Bought at .1000:

Aug 28: 245,000
Aug 31: 55,512
Sep 4: 9,905
Sep 12: 5,000
Feb 20: 5
Feb 26: 100
Feb 27: 528
Feb 28: 850
Mar 1: 65
Mar 4: 1
Mar 6: 206
Mar 8: 3,277
Mar 19: 300
Apr 2: 4,397
Apr 3: 167
Apr 4: 1,202
Apr 5: 1,500
Apr 15: 2,923
Apr 22: 1
Apr 23: 201
May 2: 2
May 7: 30
May 10: 1
May 14: 1,363
May 15: 55
May 21:18
May 23: 1,000
Jul 1: 2,000
Sep 4: 15,821 [all bought on ask]
Oct 7: 4,000
Oct 9: 1,000
Oct 10: 7,175
Oct 11: 8,325

Total: 371,930

Bought at .0900:

Sep 12: 995

Bought at .080 / .0850 / .0875:

Sep 10: 3,370
Sep 11: 3,099
Oct 7: 4
Oct 10: 1,500 [bought by invisible bidder at .1000]
Oct 11: 10 [bought by invisible bidder at .1000]

Total: 4,984

Bought at .0701 / .0750 / .0751:

Sep 5: 26
Sep 6: 2,917
Sep 7: 4,926
Sep 10: 6,390
Oct 14: 1,145 [paint down set at .0751 below invisible bid much higher]
Oct 16: 13,599 [paint down set at .0750 below invisible bid much higher]
Oct 21: 25 [paint down set at .0750 below invisible bid much higher]
Oct 24: 100 [paint down set at .0750 below invisible bid much higher]
Oct 25: 1,500 [paint down set at .0750 below invisible bid much higher]
Oct 29: 10 [paint down set at .0750 below invisible bid much higher]

Total: 30,238


Bought at .0050 > .0700:

May 28: 4,300 [ignoring 3,800 short / cover mirror trade]
Jun 18: 1,000 [filling hidden bid at .1000 from shorted paint down]
Jul 19: 500 [filling hidden bid from paint down]
Jul 23: 1,000
Jul 24: 7,000
Sep 3: 625 [paint down bought at .0160]
Sep 13: 1,000 [paint down bought at .0160]
Sep 17: 390 [paint down bought mainly at .0120]
Sep 24: 475 [paint down bought at .0150]
Oct 18: 250 [paint down set at .0385 below invisible bid much higher]
Oct 21: 50 [paint down set at .0385 below invisible bid much higher]

Total: 16,590

Notes:
Nobody had .1s (.0001s) previously.
Very few had .2 (.0002s) previously - only 5M from 2018 prior to Aug 28.






American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 354

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 26

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 129

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 27

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 50

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 294

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading

Top 5 Most Recently Viewed Articles

Iceland Seafood International hf Announces Successful Bill Auction

Updated Category News Views 171

Iceland Seafood International hf's Successful Auction Iceland Seafood International hf. has recently completed an offering of 3-month bills under the new series ICESEA 25 0304. This significant milestone reflects the company's ongoing efforts to strengthen its financial position and enhance its market presence. Details of the Bill Auction The total offers for the bills...

Continue Reading
Prolong Pharmaceuticals Showcases PP-007 in Innovative Stroke Study

Updated Category News Views 194

Prolong Pharmaceuticals Highlights Phase 1 Results for Acute Ischemic Stroke Treatment Prolong Pharmaceuticals, LLC, a clinical-stage biopharmaceutical firm, is making waves in the medical community with its recent announcement regarding the preliminary data from the HEMERA-1 trial. This significant study looks into the effects of their lead asset, PP-007, in treating...

Continue Reading
Investors Urged to Join Class Action Against Verve Therapeutics

Updated Category News Views 89

Investors: Consider Joining the Verve Therapeutics Class Action Robbins LLP, a shareholder-rights law firm, is reminding investors about an important window to act in the class action against Verve Therapeutics, Inc. (NASDAQ: VERV). The lawsuit covers individuals and entities that bought or otherwise acquired Verve securities during a defined time frame. Verve is a...

Continue Reading
Top Dividend Stocks for Passive Income Success

Updated Category News Views 246

Building Passive Income Through Smart Investments Creating passive income is a crucial element of a successful early retirement plan. Establishing various sources of passive income is important to reduce the pressure of depending solely on active work for financial support. A key aspect of this strategy is investing in companies known for their above-average dividends,...

Continue Reading
Temperature Monitoring Devices Market Expected to Surge

Updated Category News Views 61

The temperature monitoring devices market experienced a notable surge back in 2024, with projections estimating a compound annual growth rate (CAGR) of 4.5% through to 2034. By the end of that forecast period, sales revenue was set to hit around USD 5.3 billion—a clear indicator of robust expansion in this critical sector. Market Dynamics: Diverse Applications Across...

Continue Reading